We are live on ! Find out more
GCM

Geneva Capital Management Portfolio holdings

AUM $4.36B
1-Year Est. Return 17.81%
This Fund
S&P 500
This Quarter Est. Return
-1.72%
1 Year Est. Return
+17.81%
3 Year Est. Return
+59.44%
5 Year Est. Return
+75.65%
10 Year Est. Return
AUM
$4.71B
AUM Growth
-$618M
Cap. Flow
-$350M
Cap. Flow %
-7.43%
Top 10 Hldgs %
32.27%
Holding
125
New
2
Increased
27
Reduced
91
Closed
5

Top Buys

Rank Stock Value
1
LOAR icon
Loar Holdings
LOAR
+$20.5M
2
LMB icon
Limbach Holdings
LMB
+$19.9M
3
CSW
CSW Industrials
CSW
+$19.5M
4
DORM icon
Dorman Products
DORM
+$18.9M
5
RGEN icon
Repligen
RGEN
+$18.3M

Sector Composition

Rank Sector Weight
1 Technology 30.74%
2 Industrials 28.22%
3 Healthcare 15.07%
4 Consumer Discretionary 9.77%
5 Financials 5.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWP icon
101
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$2.99M 0.06%
23,359
-41,304
-64% -$5.59M
TJX icon
102
TJX Companies
TJX
$178B
$2.71M 0.06%
16,962
-5,165
-23% -$804K
GOOGL icon
103
Alphabet (Google) Class A
GOOGL
$4.33T
$2.62M 0.06%
9,100
-1,756
-16% -$552K
MRVL icon
104
Marvell Technology
MRVL
$196B
$2.59M 0.06%
26,194
-4,966
-16% -$417K
WMT icon
105
Walmart Inc
WMT
$890B
$2.43M 0.05%
19,516
-3,769
-16% -$463K
FBIN icon
106
Fortune Brands Innovations
FBIN
$6.06B
$2.32M 0.05%
59,654
-3,219
-5% -$167K
COST icon
107
Costco
COST
$420B
$2.22M 0.05%
2,232
-726
-25% -$707K
CRL icon
108
Charles River Laboratories
CRL
$12.8B
$2.06M 0.04%
11,942
-214
-2% -$39.7K
TMO icon
109
Thermo Fisher Scientific
TMO
$220B
$2.04M 0.04%
4,146
-785
-16% -$426K
MSFT icon
110
Microsoft
MSFT
$3.71T
$1.95M 0.04%
5,262
-1,011
-16% -$423K
V icon
111
Visa
V
$677B
$1.82M 0.04%
6,029
-1,166
-16% -$375K
EW icon
112
Edwards Lifesciences
EW
$51.7B
$1.7M 0.04%
21,243
+4,091
+24% +$337K
MSI icon
113
Motorola Solutions
MSI
$77.4B
$1.59M 0.03%
3,672
-696
-16% -$301K
ISRG icon
114
Intuitive Surgical
ISRG
$134B
$1.52M 0.03%
3,294
-627
-16% -$317K
LOW icon
115
Lowe's Companies
LOW
$125B
$1.52M 0.03%
6,414
-1,248
-16% -$325K
ECL icon
116
Ecolab
ECL
$79.9B
$1.48M 0.03%
5,557
-1,062
-16% -$300K
SPGI icon
117
S&P Global
SPGI
$120B
$1.18M 0.03%
2,769
-527
-16% -$245K
VLTO icon
118
Veralto
VLTO
$24B
$816K 0.02%
9,226
-1,752
-16% -$167K
CRM icon
119
Salesforce
CRM
$158B
$747K 0.02%
4,004
-761
-16% -$158K
DHR icon
120
Danaher
DHR
$144B
$673K 0.01%
3,547
-5,219
-60% -$1.11M
AZTA icon
121
Azenta
AZTA
$1.48B
-463,408
Closed -$15.4M
IJK icon
122
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
-2,582
Closed -$250K
MLAB icon
123
Mesa Laboratories
MLAB
$574M
-178,713
Closed -$14M
MRTN icon
124
Marten Transport
MRTN
$1.22B
-1,868,567
Closed -$21.3M
SPSC icon
125
SPS Commerce
SPSC
$2.64B
-281,354
Closed -$25.1M

Similar funds

Geneva Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Geneva Capital Management held 125 positions worth $4.71B, down 12% from $5.32B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Geneva Capital Management withdrew a net $350M in Q1 2026, closing 5 positions and reducing 91 holdings. Its most notable exit was SPS Commerce, an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Geneva Capital Management opened a new position in Limbach Holdings worth $18.4M.

  • Geneva Capital Management's largest Q1 2026 buy was Limbach Holdings: 236,090 shares worth $18.4M.
  • Geneva Capital Management added most to Loar Holdings in Q1 2026, an estimated $20.5M increase.
  • Geneva Capital Management's biggest Q1 2026 reduction was RBC Bearings, cutting an estimated $70.5M.
  • Geneva Capital Management fully exited SPS Commerce in Q1 2026, selling an estimated $25.1M.
  • Geneva Capital Management's ten largest holdings make up 32% of its $4.71B portfolio in Q1 2026.
  • Geneva Capital Management opened 2 new positions and closed 5 in Q1 2026.
  • Geneva Capital Management's portfolio value fell 12% quarter-over-quarter to $4.71B.

Based on Geneva Capital Management's 13F filing for Q1 2026, filed 6 May 2026.